Indenture Agreements in the Life Sciences Tools & Services Industry

106 Contracts & Agreements

Browse by Company

Agilent Technologies Inc (19 contracts)
Avantor, Inc. (1)
Bio-Rad Laboratories (3)
Charles River Laboratories (6)
FLUIDIGM CORP (4)
Illumina Inc (2)
IQVIA Holdings Inc. (11)
Luminex Corporation (1)
NanoString Technologies Inc (1)
NEOGENOMICS INC (1)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (3)
PerkinElmer (6)
PPD, Inc. (4)
Repligen Corporation (8)
Syneos Health (8)
Thermo Fisher Scientific (28)

Recent Contracts

Third Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on September 9, 2024)
Second Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on September 9, 2024)
Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as... (IQVIA Holdings Inc., Filed With SEC on July 22, 2024)
Supplemental Indenture, dated as of June 27, 2024, among the subsidiary guarantors named on the signature pages thereto and U.S. Bank Trust Company, National Association, as... (IQVIA Holdings Inc., Filed With SEC on July 22, 2024)
Indenture, dated as of December 14, 2023, between Repligen Corporation and Wilmington Trust, National Association, as Trustee (Repligen Corporation, Filed With SEC on December 15, 2023)
Twenty-Eighth Supplemental Indenture, dated as of December 5, 2023, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on December 5, 2023)
Indenture, dated November 28, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes and the Company and certain subsidiaries of... (IQVIA Holdings Inc., Filed With SEC on November 28, 2023)
Twenty-Seventh Supplemental Indenture, dated as of August 10, 2023, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on August 10, 2023)
Indenture, dated as of June 30, 2023, by and between Pacific Biosciences of California, Inc. and U.S. Bank Trust Company, National Association, as Trustee (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on June 30, 2023)
Indenture, dated May 23, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the Senior Notes and certain subsidiaries of the Issuer as... (IQVIA Holdings Inc., Filed With SEC on May 23, 2023)
Indenture, dated May 23, 2023, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the Senior Secured Notes and the Company and certain... (IQVIA Holdings Inc., Filed With SEC on May 23, 2023)
Twenty-Sixth Supplemental Indenture, dated as of November 21, 2022, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on November 21, 2022)
Twenty-Fifth Supplemental Indenture, dated as of November 21, 2022, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on November 21, 2022)
Fifth Supplemental Indenture, dated as of October 3, 2022, among the Guaranteeing Subsidiaries, the Company, the other Guarantors, and Wells Fargo Bank, National Association, as... (Syneos Health, Filed With SEC on November 4, 2022)
Twenty-Fourth Supplemental Indenture, dated as of October 20, 2022, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on October 20, 2022)
Fourth Supplemental Indenture, dated as of April 5, 2022, among the Guaranteeing Subsidiaries, the Company, the other Guarantors, and Wells Fargo Bank, National Association, as... (Syneos Health, Filed With SEC on April 29, 2022)
Second Supplemental Indenture, dated as of March 4, 2022, by and between Repligen Corporation and Wilmington Trust, National Association, as trustee (Repligen Corporation, Filed With SEC on March 8, 2022)
First Supplemental Indenture, dated as of March 2, 2022, by and between Bio-Rad Laboratories, Inc. and Wilmington Trust, National Association (Bio-Rad Laboratories, Filed With SEC on March 2, 2022)
Indenture, dated as of March 2, 2022, by and between Bio-Rad Laboratories, Inc. and Wilmington Trust, National Association (Bio-Rad Laboratories, Filed With SEC on March 2, 2022)
Third Supplemental Indenture, dated as of November 19, 2021, among the Company, the subsidiary guarantors named on the signature pages thereto, the other guarantors, and Wells... (Syneos Health, Filed With SEC on February 17, 2022)
Fourth Supplemental Indenture, dated as of November 18, 2021, among Thermo Fisher International, as issuer, the Company, as guarantor, and The Bank of New York Mellon Trust... (Thermo Fisher Scientific, Filed With SEC on November 18, 2021)
Indenture, dated as of October 26, 2021, among Avantor Funding, Inc., the guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as Trustee (Avantor, Inc., Filed With SEC on October 26, 2021)
Twenty-Third Supplemental Indenture, dated as of October 22, 2021, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on October 22, 2021)
Third Supplemental Indenture, dated as of October 18, 2021, among Thermo Fisher International, as issuer, the Company, as guarantor, and The Bank of New York Mellon Trust Company,... (Thermo Fisher Scientific, Filed With SEC on October 18, 2021)
Seventh Supplemental Indenture, dated as of September 10, 2021, by and between the Company and U.S. Bank National Association, as trustee (including the form of note contained... (PerkinElmer, Filed With SEC on September 10, 2021)
Twenty-Second Supplemental Indenture, dated as of August 23, 2021, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Thermo Fisher Scientific, Filed With SEC on August 23, 2021)
Second Supplemental Indenture, dated as of May 25, 2021, among the Company, the subsidiary guarantors named on the signature pages thereto, the other guarantors, and Wells Fargo... (Syneos Health, Filed With SEC on August 9, 2021)
First Supplemental Indenture, dated as of March 23, 2021, by and among the Company, the Guarantors and U.S. Bank National Association, as trustee (Charles River Laboratories, Filed With SEC on March 23, 2021)
Indenture, dated as of March 23, 2021, between the Company and U.S. Bank National Association, as trustee (Charles River Laboratories, Filed With SEC on March 23, 2021)
First Supplemental Indenture, dated as of March 12, 2021, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on March 12, 2021)
Indenture, dated as of March 12, 2021, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on March 12, 2021)
Sixth Supplemental Indenture, dated as of March 8, 2021, by and between the Company and U.S. Bank National Association, as trustee (including the form of note contained therein) (PerkinElmer, Filed With SEC on March 8, 2021)
Indenture, dated February 16, 2021, between Pacific Biosciences of California, Inc. and U.S. Bank National Association, as Trustee (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 17, 2021)
Form of Indenture related to 1.50% Convertible Senior Notes due 2028 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 10, 2021)
Indenture, dated January 11, 2021, by and between the Company and U.S. Bank National Association, as Trustee (NEOGENOMICS INC, Filed With SEC on January 11, 2021)
First Supplemental Indenture, dated as of November 24, 2020, between the Company, the subsidiary guarantors named on the signature pages thereto and Wells Fargo Bank, National... (Syneos Health, Filed With SEC on November 25, 2020)
Indenture, dated as of November 24, 2020, between the Company and Wells Fargo Bank, National Association, as trustee (Syneos Health, Filed With SEC on November 25, 2020)
Indenture, dated as of June 5, 2020 by and among, Jaguar Holding Company II, PPD Development, L.P, the guarantors time to time party thereto and Wilmington Trust, National... (PPD, Inc., Filed With SEC on June 5, 2020)
Second Supplemental Indenture, dated as of June 4, 2020, between the Company and U.S. Bank National Association (Agilent Technologies Inc, Filed With SEC on June 4, 2020)
Indenture dated as of May 13, 2020 between the Registrant and the Trustee (Luminex Corporation, Filed With SEC on May 13, 2020)